Alexis Gil II Sells 25,901 Shares of Integral Ad Science (NASDAQ:IAS) Stock

Key Points

• Alexis Gil II, the CAO of Integral Ad Science, sold 25,901 shares of the company's stock at an average price of $10.18, reducing his ownership by 15.14%.
• Integral Ad Science reported earnings of $0.07 per share, exceeding analysts' expectations, with revenue of $149.20 million for the last quarter.
• Analysts have mixed ratings on the stock, with Barclays raising its price target to $10.00 and others downgrading their ratings, reflecting varied investor sentiment.

Integral Ad Science Holding Corp. (NASDAQ:IAS - Get Free Report) CAO Alexis Gil II sold 25,901 shares of the firm's stock in a transaction dated Wednesday, September 24th. The stock was sold at an average price of $10.18, for a total value of $263,672.18. Following the completion of the transaction, the chief accounting officer directly owned 145,140 shares in the company, valued at $1,477,525.20. The trade was a 15.14% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Alexis Gil II also recently made the following trade(s):

• On Monday, July 7th, Alexis Gil II sold 1,962 shares of Integral Ad Science stock. The stock was sold at an average price of $8.43, for a total value of $16,539.66.

Integral Ad Science Stock Down 0.0%

NASDAQ:IAS traded down $0.01 on Friday, hitting $10.17. The stock had a trading volume of 604,959 shares, compared to its average volume of 1,403,340. The stock has a market cap of $1.69 billion, a price-to-earnings ratio of 29.90, a price-to-earnings-growth ratio of 1.45 and a beta of 1.57. The business's 50-day simple moving average is $8.68 and its two-hundred day simple moving average is $8.17. Integral Ad Science Holding Corp. has a 52-week low of $6.26 and a 52-week high of $13.62.

Integral Ad Science (NASDAQ:IAS - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The company reported $0.07 earnings per share for the quarter, beating analysts' consensus estimates of $0.04 by $0.03. Integral Ad Science had a return on equity of 5.00% and a net margin of 9.79%.The firm had revenue of $149.20 million for the quarter, compared to analysts' expectations of $143.02 million. Integral Ad Science has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. As a group, equities research analysts anticipate that Integral Ad Science Holding Corp. will post 0.26 EPS for the current year.

Analyst Upgrades and Downgrades

IAS has been the topic of a number of research reports. Barclays lifted their price objective on Integral Ad Science from $9.00 to $10.00 and gave the stock an "equal weight" rating in a research note on Friday, August 8th. Wall Street Zen raised Integral Ad Science from a "hold" rating to a "buy" rating in a research note on Sunday, August 10th. Oppenheimer downgraded Integral Ad Science from an "outperform" rating to a "market perform" rating in a research note on Wednesday. BMO Capital Markets set a $10.30 target price on Integral Ad Science and gave the company a "market perform" rating in a research report on Wednesday. Finally, Loop Capital downgraded Integral Ad Science from a "buy" rating to a "hold" rating and set a $10.30 price objective on the stock. in a research report on Wednesday. Two equities research analysts have rated the stock with a Buy rating and twelve have assigned a Hold rating to the company's stock. According to MarketBeat, Integral Ad Science has an average rating of "Hold" and a consensus target price of $12.81.

Hedge Funds Weigh In On Integral Ad Science

Hedge funds and other institutional investors have recently modified their holdings of the stock. GAMMA Investing LLC raised its position in shares of Integral Ad Science by 547.1% in the 1st quarter. GAMMA Investing LLC now owns 3,313 shares of the company's stock valued at $270,000 after purchasing an additional 2,801 shares during the last quarter. State of Wyoming acquired a new stake in Integral Ad Science during the fourth quarter worth about $51,000. DekaBank Deutsche Girozentrale acquired a new stake in Integral Ad Science during the first quarter worth about $42,000. CWM LLC grew its holdings in Integral Ad Science by 1,248.1% during the second quarter. CWM LLC now owns 9,019 shares of the company's stock worth $75,000 after acquiring an additional 8,350 shares during the period. Finally, Tower Research Capital LLC TRC grew its holdings in Integral Ad Science by 136.5% during the second quarter. Tower Research Capital LLC TRC now owns 10,158 shares of the company's stock worth $84,000 after acquiring an additional 5,862 shares during the period. 95.78% of the stock is owned by hedge funds and other institutional investors.

About Integral Ad Science

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.